Triple-negative breast cancers (TNBCs) represent 15% of all breast cancers (BCs) and are defined by the absence of estrogen receptors (ERs), progesterone receptors (PRs), and HER2 overexpression/amplification [1,2]. Here, ESR1 is linked to breast cancer.